CONFORM Investigators & Research Teams,
I am pleased to share with you that the acquisition of Conformal Medical by W. L. Gore & Associates is now complete.
Joining the Gore Enterprise represents an important next chapter for Conformal Medical. This milestone strengthens our ability to advance the CONFORM Pivotal Trial with the CLAAS® AcuFORM™ technology while maintaining the same team, commitment, and level of service you expect from Conformal Medical. Gore’s experience in medical technology development and its commitment to innovation will enable us to benefit from their science-driven approach and long-time commitment to improving patient care. If you are interested in learning more about the acquisition and about Gore, please see the press release via the link below.
Conformal Medical will continue to operate as a wholly owned subsidiary of Gore within its Medical business. Importantly, our mission and priorities remain unchanged. We are fully focused on the ongoing CONFORM Pivotal Trial and will continue to actively support CONFORM clinical sites with enrollment and trial-related needs. Thank you to all our sites for your support and efforts as we work towards completing the trial.
We would not be where we are today without your dedication to advancing clinical research.
Regards,
James Reinstein
President and CEO
.png?upscale=true&width=300&upscale=true&name=Conformal%20Logo%20-%20Wordmark%20(Inverse%2c%20RGB).png)
